Journal of Oncology Therapeutics and Drug Development

About the Journal

The Journal of Oncology Therapeutics and Drug Development is a multidisciplinary, peer-reviewed platform dedicated to advancing research in cancer treatment innovation and pharmaceutical development. The journal focuses on the discovery, optimization, and clinical evaluation of novel anticancer agents including small molecules, biologics, targeted therapies, immunotherapies, and combination strategies.

Its scope encompasses the full spectrum of oncology drug development, from preclinical mechanistic studies and translational research to clinical trial outcomes, biomarker discovery, and therapeutic optimization. The journal also highlights emerging technologies such as nanomedicine, precision oncology, AI-driven drug design, and advanced delivery systems aimed at improving therapeutic index and patient outcomes.

By bringing together researchers, clinicians, pharmacologists, and industry professionals, the Journal of Oncology Therapeutics and Drug Development serves as a comprehensive resource for cutting-edge advancements shaping the future of cancer therapy. The journal is committed to fostering innovation, reducing the burden of cancer, and accelerating the development of safer, more effective oncology therapeutics.

Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at support@globalmeetx.com

Rapid Publication Service

Globalmeetx Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.